Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Acta Diabetologica
Metadata
Title
Influence of diabetes on peripheral bone mineral density in men: a controlled study
Authors
M. J. Bridges
S. H. Moochhala
J. Barbour
C. A. Kelly
Publication date
01-06-2005
Publisher
Springer-Verlag
Published in
Acta Diabetologica / Issue 2/2005
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-005-0183-1

Other articles of this Issue 2/2005

Acta Diabetologica 2/2005 Go to the issue

ORIGINAL

Glycogen accumulation in renal tubules, a key morphological change in the diabetic rat kidney

ORIGINAL

Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity

ORIGINAL

Prevalence of aspirin resistance in patients with type 2 diabetes

ORIGINAL

Regression of microalbuminuria in type 1 diabetic patients: results of a sequential intervention with improved metabolic control and ACE inhibitors

ORIGINAL

Anaesthesia-induced hyperglycaemia early in life is not predictive for development of diabetes in diabetes-prone BB rats

ORIGINAL

Oxidative stress in kidney and liver of alloxan-induced diabetic rabbits: effect of repaglinide

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits